Delivery Order SPE2DB24D1205-SPE2DB24FCSJF

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,593.98, is for the delivery of montelukast sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,362.49, is for the delivery of Montelukast Sodium 4 mg Granules, a generic pharmaceutical product used for asthma and allergy treatment. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award, valued at $1,638.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Montelukast Sodium 10 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,054.96 firm fixed-price contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and allergies. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,210.64 firm fixed-price delivery order is for 4,564,702,344 units of Montelukast Sodium 4 mg Granules, a medication used to treat asthma and allergies. The contract has a completion date of May 24, 2024 and was awarded on May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,163.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and other respiratory conditions. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Montelukast Sodium 10 mg tablets. The award, valued at $1,171.19, is a firm fixed-price delivery order contract with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,022.88, is for the delivery of 1,000 units of the prescription drug Montelukast Sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at up to $999,999,999.00 and runs through December 31, 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,628 units of Montelukast Sodium 5 mg Chewable Tablets. The $1,305.22 firm fixed-price contract has an ultimate completion date of October 30, 2023. This award is a delivery order against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $1,125.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg chewable tablets in 90-count packages, with a completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSJF
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.64 fixed-price delivery order is for Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any major subcontractors. This contract supports the DLA's role in supplying medical products to federal government agencies, particularly military and veterans' healthcare systems.

Generated 5/17/25, 9:50 AM